NuVasive (NUVA) Shares Higher as BMO Upgrades to Outperform

Shares of NuVasive (NASDAQ: NUVA) are up more than 3 percent Thursday morning following an earlier upgrade from an analyst at BMO Capital.

The firm boosted its investment rating on the stock from Market Perform to Outperform. BMO lifted its price target on NUVA shares from $32 to $40.

With NuVasisve shares last trading at $33.26, BMO's new price target suggests potential upside of about 20 percent.

For more ratings news on NuVasive click here and for the rating history of NuVasive click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
• BofA Securities Upgrades Solaria Energia y Medio Ambiente SA (SLR:SM) to Buy
• BMO Capital Starts Ionis Pharmaceuticals (IONS) at Market Perform